Does Zai Lab's Steep 86.2% Slide Mask a Long Term Value Opportunity? [Yahoo! Finance]
Zai Lab Limited - American Depositary Shares (ZLAB)
US:NASDAQ Investor Relations:
zailaboratory.com/about/investors.php
Company Research
Source: Yahoo! Finance
The stock has slid sharply, down 6.7% over the last week, 18.3% over the last month, and a striking 86.2% over five years, which tells us sentiment has been under pressure even as investors keep one eye on the long term growth story. Recently, the spotlight has been on Zai Lab's pipeline progress and strategic partnerships in oncology and autoimmune diseases, as the company continues to expand access to innovative therapies in China and beyond. At the same time, shifting risk appetite in biotech and changing views on commercial execution have kept the share price volatile, giving us more to unpack than a simple chart can show. On our checklist of 6 valuation tests, Zai Lab scores a for being undervalued, which suggests the market might be underestimating parts of the story, but not giving it a free pass either. Next, we will break down the main valuation approaches and then wrap up with a more holistic way to judge what the stock is truly worth. Find out why Zai Lab's -32.1% re
Show less
Read more
Impact Snapshot
Event Time:
ZLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZLAB alerts
High impacting Zai Lab Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ZLAB
News
- Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic DermatitisBusiness Wire
- Zai Lab Announces Updates to China's National Reimbursement Drug List [Yahoo! Finance]Yahoo! Finance
- Zai Lab Announces Updates to China’s National Reimbursement Drug ListBusiness Wire
- Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum [Yahoo! Finance]Yahoo! Finance
- Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy) [Seeking Alpha]Seeking Alpha
ZLAB
Earnings
- 11/6/25 - Miss
ZLAB
Sec Filings
- 12/12/25 - Form 4
- 11/25/25 - Form 4
- 11/21/25 - Form 144
- ZLAB's page on the SEC website